Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'SOMATOSTATIN ANALOGS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 129 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Virgolini, I; Traub, T; Novotny, C; Leimer, M; Fuger, B; Li, SR; Patri, P; Pangerl, T; Angelberger, P; Raderer, M; Andreae, F; Kurtaran, A; Dudczak, R
      New trends in peptide receptor radioligands

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    2. Bayer, T; Riemer, C; Kessler, H
      A new strategy for the synthesis of cyclopeptides containing diaminoglutaric acid

      JOURNAL OF PEPTIDE SCIENCE
    3. de Murphy, CA; Pedraza-Lopez, M; Ferro-Flores, G; Murphy-Stack, E; Chavez-Mercado, L; Ascencio, JA; Garcia-Salinas, L; Hernandez-Gutierrez, S
      Uptake of Re-188-beta-naphthyl-peptide in cervical carcinoma tumours in athymic mice

      NUCLEAR MEDICINE AND BIOLOGY
    4. Dogliotti, L; Tampellini, M; Stivanello, A; Gorzegno, G; Fabiani, L
      The clinical management of neuroendocrine tumors with long-acting repeatable (LAR) octreotide: Comparison with standard subcutaneous octreotide therapy

      ANNALS OF ONCOLOGY
    5. Hansson, J; Abrahamsson, PA
      Neuroendocrine pathogenesis in adenocarcinoma of the prostate

      ANNALS OF ONCOLOGY
    6. Attanasio, R; Barausse, M; Cozzi, R
      GH/IGF-I normalization and tumor shrinkage during long-term treatment of acromegaly by lanreotide

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    7. Chen, XJ; Liu, ZS; Ai, ZL
      Antineoplastic mechanism of Octreotide action in human hepatoma

      CHINESE MEDICAL JOURNAL
    8. Di Luigi, L; Guidetti, L; Nordio, M; Baldari, C; Romanelli, F
      Acute effect of physical exercise on serum insulin-like growth factor-binding protein 2 and 3 in healthy men: Role of exercise-linked growth hormone secretion

      INTERNATIONAL JOURNAL OF SPORTS MEDICINE
    9. Schally, AV; Comaru-Schally, AM; Nagy, A; Kovacs, M; Szepeshazi, K; Plonowski, A; Varga, JL; Halmos, G
      Hypothalamic hormones and cancer

      FRONTIERS IN NEUROENDOCRINOLOGY
    10. Tulipano, G; Bonfanti, C; Milani, G; Billeci, B; Bollati, A; Cozzi, R; Maira, G; Murphy, WA; Poiesi, C; Turazzi, S; Giustina, A
      Differential inhibition of growth hormone secretion by analogs selective for somatostatin receptor subtypes 2 and 5 in human growth-hormone-secretingadenoma cells in vitro

      NEUROENDOCRINOLOGY
    11. Cannavo, S; Squadrito, S; Curto, L; Almoto, B; Trimarchi, F
      Effectiveness of slow-release lanreotide in previously operated and untreated patients with GH-secreting pituitary macroadenoma

      HORMONE AND METABOLIC RESEARCH
    12. Boccardo, F; Amoroso, D
      Management of breast cancer: Is there a role for somatostatin and its analogs?

      CHEMOTHERAPY
    13. Cascinu, S; Catalano, V; Giordani, P; Baldelli, AM; Agostinelli, R; Catalano, G
      Gastrointestinal cancer refractory to chemotherapy: A role for octreotide?

      CHEMOTHERAPY
    14. Rosenberg, L
      Pancreatic cancer: Does octreotide offer any promise?

      CHEMOTHERAPY
    15. Jenkins, SA; Kynaston, HG; Davies, N; Baxter, JN; Nott, DM
      Somatostatin analogs in oncology: A look to the future

      CHEMOTHERAPY
    16. Reubi, JC; Gugger, M; Waser, B; Schaer, JC
      Y-1-mediated effect of neuropeptide Y in cancer: Breast carcinomas as targets

      CANCER RESEARCH
    17. Sviri, S; Muszkat, M; Shapira, MY; Gross, D; Linton, DM
      Fulminant Cushing's syndrome due to an ACTH-producing thymic carcinoid

      ISRAEL MEDICAL ASSOCIATION JOURNAL
    18. Oberg, K
      State of the art and future prospects in the management of neuroendocrine tumors

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    19. Virgolini, I; Traub, T; Leimer, M; Novotny, C; Pangerl, T; Ofluoglu, S; Halvadjieva, E; Smith-Jones, P; Flores, J; Li, SR; Angelberger, P; Havlik, E; Andreae, F; Raderer, M; Kurtaran, A; Niederle, B; Dubczak, R
      New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    20. Friend, KE
      Targeting the growth hormone axis as a therapeutic strategy in oncology

      GROWTH HORMONE & IGF RESEARCH
    21. Huynh, H; Beamer, W; Pollak, M; Chan, TWMG
      Modulation of transforming growth factor beta 1 gene expression in the mammary gland by insulin-like growth factor I and octreotide

      INTERNATIONAL JOURNAL OF ONCOLOGY
    22. Baulieu, JL; Resche, I; Bardies, M; Chauvet, AF; Lecloirec, J; Malhaire, JP; Thomas, E; Faurous, P; Sassolas, G; Pourcelot, L; Chatal, JF; Guilloteau, D; Besnard, JC
      [I-131]-TYR3-octreotide: Clinical dosimetry and use for internal radiotherapy of metastatic paraganglioma and carcinoid tumors

      NUCLEAR MEDICINE AND BIOLOGY
    23. Allen, MP; Blake, JF; Bryce, DK; Haggan, ME; Liras, S; McLean, S; Segelstein, BE
      Design, synthesis and biological evaluation of 3-amino-3-phenylpropionamide derivatives as novel mu opioid receptor ligands

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    24. Ding, XZ; Fehsenfeld, DM; Murphy, LO; Permert, J; Adrian, TE
      Physiological concentrations of insulin augment pancreatic cancer cell proliferation and glucose utilization by activating MAP kinase, PI3 kinase andenhancing GLUT-1 expression

      PANCREAS
    25. Duarte, PS; Aldighieri, F; Maciel, RMB; Kater, C; Martins, LRF; Alonso, G
      Uptake of In-111 octreotide in the retrobulbar space in a patient with thyroid ophthalmopathy

      CLINICAL NUCLEAR MEDICINE
    26. Wenger, FA; Kilian, M; Mautsch, I; Jacobi, CA; Schimke, I; Saul, GJ; Guski, H; Muller, JM
      Influence of octreotide and tamoxifen on tumor growth and liver metastasisin N-nitrosobis(2-oxopropyl)amine-induced pancreatic cancer in Syrian hamsters

      HORMONE RESEARCH
    27. Vaccarill, M; Lococo, A; Fabiani, F; Staffilano, A
      Clinical diagnostic application of In-111-DTPA-octreotide scintigraphy in small cell lung cancer

      TUMORI
    28. Schally, AV; Comaru-Schally, AM; Plonowski, A; Nagy, A; Halmos, G; Rekasi, Z
      Peptide analogs in the therapy of prostate cancer

      PROSTATE
    29. Chisholm, C; Greenberg, GR
      Somatostatin receptor subtype-5 mediates inhibition of peptide YY secretion from rat intestinal cultures

      AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    30. Mattern, RH; Moore, SB; Tran, TA; Rueter, JK; Goodman, M
      Synthesis, biological activities and conformational studies of somatostatin analogs

      TETRAHEDRON
    31. Schiller, PW; Berezowska, I; Nguyen, TMD; Schmidt, R; Lemieux, C; Chung, NN; Falcone-Hindley, ML; Yao, WQ; Liu, J; Iwama, S; Smith, AB; Hirschmann, R
      Novel ligands lacking a positive charge for the delta- and mu-opioid receptors

      JOURNAL OF MEDICINAL CHEMISTRY
    32. Bonner, GG; Davis, P; Stropova, D; Edsall, S; Yamamura, HI; Porreca, F; Hruby, VJ
      Opiate aromatic pharmacophore structure-activity relationships in CTAP analogues determined by topographical bias, two-dimensional NMR, and biological activity assays

      JOURNAL OF MEDICINAL CHEMISTRY
    33. Arosio, M; Sartore, G; Rossi, CM; Casati, G; Faglia, G; Manzato, E
      LDL physical properties, lipoprotein and Lp(a) levels in acromegalic patients. Effects of octreotide therapy

      ATHEROSCLEROSIS
    34. Achilefu, S; Dorshow, RB; Bugaj, JE; Rajagopalan, R
      Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging

      INVESTIGATIVE RADIOLOGY
    35. Mattern, RH; Zhang, L; Rueter, JK; Goodman, M
      Conformational analyses of sandostatin analogs containing stereochemical changes in positions 6 or 8

      BIOPOLYMERS
    36. Demir, T; Celiker, UO; Kukner, A; Mogulkoc, R; Celebi, S; Celiker, H
      Effect of Octreotide on experimental corneal neovascularization

      ACTA OPHTHALMOLOGICA SCANDINAVICA
    37. Modlin, IM; Tang, LH
      Cell and tumour biology of the gastric enterochromaffin-like cell

      ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    38. Mattern, RH; Tran, TA; Goodman, M
      Conformational analyses of cyclic hexapeptide analogs of somatostatin containing arylalkyl peptoid and naphthylalanine residues

      JOURNAL OF PEPTIDE SCIENCE
    39. Tran, TA; Mattern, RH; Morgan, BA; Taylor, JE; Goodman, M
      Synthesis and binding potencies of cyclohexapeptide somatostatin analogs containing naphthylalanine and arylalkyl peptoid residues

      JOURNAL OF PEPTIDE SCIENCE
    40. Cuntz, MC; Levine, EA; O'Dorisio, TM; Watson, JC; Wray, DA; Espenan, GD; McKnight, C; Meier, JR; Weber, LJ; Mera, R; O'Dorisio, MS; Woltering, EA
      Intraoperative gamma detection of I-125-lanreotide in women with primary breast cancer

      ANNALS OF SURGICAL ONCOLOGY
    41. Lester, NV; Newell, SM; Hill, RC; Lanz, OI
      Scintigraphic diagnosis of insulinoma in a dog

      VETERINARY RADIOLOGY & ULTRASOUND
    42. Kolle, S; Sinowatz, F; Boie, G; Temmim-Baker, L; Lincoln, D
      Expression of growth hormone receptor in human prostatic carcinoma and hyperplasia

      INTERNATIONAL JOURNAL OF ONCOLOGY
    43. Decristoforo, C; Mather, SJ
      99m-technetium-labelled peptide-HYNIC conjugates: Effects of lipophilicityand stability on biodistribution

      NUCLEAR MEDICINE AND BIOLOGY
    44. Eriksson, B; Oberg, K
      Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors: Future outlook

      ANNALS OF ONCOLOGY
    45. Schally, AV; Nagy, A
      Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    46. Colao, A; Marzullo, P; Ferone, D; Marino, V; Pivonello, R; Di Somma, C; Di Sarno, A; Giaccio, A; Lombardi, G
      Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    47. Spraul, CW; Kaven, C; Kampmeier, J; Lang, GK; Lang, GE
      Effect of thalidomide, octreotide, and prednisolone on the migration and proliferation of RPE cells in vitro

      CURRENT EYE RESEARCH
    48. Mantke, R; Manger, T; Schulz, HU; Ridwelski, K; Pross, M; Gunther, T; Lippert, H
      Multimodal treatment of neuroendocrine tumors of the pancreas and the ampulla of Vater

      DIGESTIVE SURGERY
    49. Ivanov, YV; Dubinin, VY; Ivanov, VV; Alekhnovich, AV
      Today's aspects of sandostatin application in gastroenterology and surgery(review of literature for 1993-1998)

      TERAPEVTICHESKII ARKHIV
    50. Frolkis, AV
      Somatostatin analogs in the treatment of gastrointestinal diseases

      TERAPEVTICHESKII ARKHIV
    51. Hruby, VJ; Agnes, RS
      Conformation-activity relationships of opioid peptides with selective activities at opioid receptors

      BIOPOLYMERS
    52. Zambre, Y; Ling, ZD; Chen, MC; Hou, X; Woon, CW; Culler, M; Taylor, JE; Coy, DH; Van Schravendijk, C; Schuit, F; Pipeleers, DG; Eizirik, DL
      Inhibition of human pancreatic islet insulin release by receptor-selectivesomatostatin analogs directed to somatostatin receptor subtype 5

      BIOCHEMICAL PHARMACOLOGY
    53. Sadoul, JL
      Somatotrope pituitary adenomas. Contribution of presurgical treatment withsomatostatin analogs

      ANNALES D ENDOCRINOLOGIE
    54. BENEVENTO A; DOMINIONI L; CARCANO G; DIONIGI R
      INTRAOPERATIVE LOCALIZATION OF GUT ENDOCRINE TUMORS WITH RADIOLABELEDSOMATOSTATIN ANALOGS AND A GAMMA-DETECTING PROBE

      Seminars in surgical oncology
    55. HUYNH H; BEAMER W
      SUPPRESSION OF MAMMARY-DERIVED GROWTH INHIBITOR GENE-EXPRESSION BY GROWTH-HORMONE AND INSULIN-LIKE-GROWTH-FACTOR-I

      International journal of oncology
    56. SMITHJONES PM; STOLZ B; ALBERT R; RUSER G; BRINER U; MACKE HR; BRUNS C
      SYNTHESIS AND CHARACTERIZATION OF [Y-90] BZ-DTPA-OCT - A YTTRIUM-90-LABELED OCTREOTIDE ANALOG FOR RADIOTHERAPY OF SOMATOSTATIN RECEPTOR-POSITIVE TUMORS

      Nuclear medicine and biology
    57. MOSBERG HI; HO JC; SOBCZYKKOJIRO K
      A HIGH-AFFINITY, MU-OPIOID RECEPTOR-SELECTIVE ENKEPHALIN ANALOG LACKING AN N-TERMINAL TYROSINE

      Bioorganic & medicinal chemistry letters
    58. Fukuda, T; Yokoyama, N; Tamai, M; Imaizumi, M; Kimura, H; Tominaga, T; Ashizawa, K; Kiriyama, T; Yoshimine, H; Ohishi, K; Eguchi, K
      Thyrotropin secreting pituitary adenoma effectively treated with octreotide

      INTERNAL MEDICINE
    59. GUNAL AI; GEZEN M; OZERCAN R; ONER H; CELIKER H
      THE EFFECT OF OCTREOTIDE ON PERITONEAL ALTERATIONS INDUCED BY HIGH-CONCENTRATION OF GLUCOSE

      Peritoneal dialysis international
    60. BREEMAN WAP; VANHAGEN PM; KWEKKEBOOM DJ; VISSER TJ; KRENNING EP
      SOMATOSTATIN RECEPTOR SCINTIGRAPHY USING [IN-111-DTPA(0)]RC-160 IN HUMANS - A COMPARISON WITH [IN-111-DTPA(0)]OCTREOTIDE

      European journal of nuclear medicine
    61. VANDENBRUEL A; BEX M; VANDORPE J; HEYNS W; BOUILLON R
      OCCULT ECTOPIC ACTH-SECRETION DUE TO RECURRENT LUNG CARCINOID - LONG-TERM CONTROL OF HYPERCORTISOLISM BY CONTINUOUS SUBCUTANEOUS INFUSION OF OCTREOTIDE

      Clinical endocrinology
    62. BREEMAN WAP; DEJONG M; BERNARD B; HOFLAND LJ; SRINIVASAN A; VANDERPLUIJM M; BAKKER WH; VISSER TJ; KRENNING EP
      TISSUE DISTRIBUTION AND METABOLISM OF RADIOIODINATED DTPA(0), D-TYR(1) AND TYR(3) DERIVATIVES OF OCTREOTIDE IN RATS

      Anticancer research
    63. PAWLIKOWSKI M; ZIELINSKI K; SLOWINSKAKLENCKA D; KLENCKI M
      EFFECTS OF OCTREOTIDE ON PROPYLTHIOURACIL-INDUCED GOITER IN RATS - A QUANTITATIVE-EVALUATION

      Histology and histopathology
    64. FUNG LC; GREENBERG GR
      SOMATOSTATIN-14 MODULATES ACID-DEPENDENT INHIBITION OF MEAL-STIMULATED GASTRIN VIA MUSCARINIC PATHWAYS IN DOGS

      Regulatory peptides
    65. Tourwe, D; Mannekens, E; Diem, TNT; Verheyden, P; Jaspers, H; Toth, G; Peter, A; Kertesz, I; Torok, G; Chung, NN; Schiller, PW
      Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile

      JOURNAL OF MEDICINAL CHEMISTRY
    66. DEMIRTAS E; SAG C; KURSAKLIOGLU H; UZUN M; UZBAY T; TORE HF; KOSE S; GENC C; DEMIRKAN D
      EFFECTS OF OCTREOTIDE IN PATIENTS WITH HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY

      Japanese Heart Journal
    67. SHOUVAL D
      OCTREOTIDE IN HEPATOCELLULAR-CARCINOMA

      Gut
    68. ROBERTSON JE; WESTRA I; WOLTERING EA; WINTHROP KL; BARRIE R; ODORISIO TM; HOLMES D
      INTRAVITREAL INJECTION OF OCTREOTIDE ACETATE

      Journal of ocular pharmacology and therapeutics
    69. THAKUR ML; KOLAN H; LI J; WIADERKIEWICZ R; PALLELA VR; DUGGARAJU R; SCHALLY AV
      RADIOLABELED SOMATOSTATIN ANALOGS IN PROSTATE-CANCER

      Nuclear medicine and biology
    70. BLISS RD; CARTER PB; LENNARD TWJ
      INSULINOMA - A REVIEW OF CURRENT MANAGEMENT

      Surgical oncology
    71. VAINAS G; PASAITOU V; GALAKTIDOU G; MARIS K; CHRISTODOULOU K; CONSTANTINIDIS C; KORTSARIS AH
      THE ROLE OF SOMATOSTATIN ANALOGS IN COMPLETE ANTIANDROGEN TREATMENT IN PATIENTS WITH PROSTATIC-CARCINOMA

      Journal of experimental & clinical cancer research
    72. BUETOW PC; MILLER DL; PARRINO TV; BUCK JL
      FROM THE ARCHIVES OF THE AFIP - ISLET-CELL TUMORS OF THE PANCREAS - CLINICAL, RADIOLOGIC, AND PATHOLOGICAL CORRELATION IN DIAGNOSIS AND LOCALIZATION

      Radiographics
    73. PAWLIKOWSKI M; KUNERTRADEK J; GROCHAL M; ZIELINSKI K; KULIG A
      THE EFFECT OF SOMATOSTATIN ANALOG OCTREOTIDE ON DIETHYLSTILBESTROL-INDUCED PROLACTIN SECRETION, CELL-PROLIFERATION AND VASCULAR CHANGES IN THE RAT ANTERIOR-PITUITARY GLAND

      Histology and histopathology
    74. SORESI E; INVERNIZZI G; BOFFI R; POSSA M; BOMBARDIERI E; CIAVARELLA GP; LIUZZI A
      INTENSIFICATION OF IN-111-DTPA-OCTREOTIDE SCINTIGRAPHY BY MEANS OF PRETREATMENT WITH COLD OCTREOTIDE IN SMALL-CELL LUNG-CANCER

      Lung cancer
    75. ROSENBERG L
      TREATMENT OF PANCREATIC-CANCER - PROMISES AND PROBLEMS OF TAMOXIFEN, SOMATOSTATIN ANALOGS, AND GEMCITABINE

      International journal of pancreatology
    76. GRADISHAR WJ
      AN OVERVIEW OF CLINICAL-TRIALS INVOLVING INHIBITORS OF ANGIOGENESIS AND THEIR MECHANISM OF ACTION

      Investigational new drugs
    77. VARGAS R; WROBLEWSKA B; REGO A; CATHAPERMAL S; RAMWELL PW
      ANGIOPEPTIN INHIBITS THYMIDINE INCORPORATION BY EXPLANTS OF PORCINE CORONARY-ARTERIES

      Journal of cardiovascular pharmacology
    78. JANMOHAMED S; BLOOM SR
      CARCINOID-TUMORS

      Postgraduate medical journal
    79. ABBRUSCATO TJ; THOMAS SA; HRUBY VJ; DAVIS TP
      BLOOD-BRAIN-BARRIER PERMEABILITY AND BIOAVAILABILITY OF A HIGHLY POTENT AND MU-SELECTIVE OPIOID RECEPTOR ANTAGONIST, CTAP - COMPARISON WITHMORPHINE

      The Journal of pharmacology and experimental therapeutics
    80. FLORIO T; SCORZIELLO A; THELLUNG S; SALZANO S; BERLINGIERI MT; FUSCO A; SCHETTINI G
      ONCOGENE TRANSFORMATION OF PC CL3 CLONAL THYROID-CELL LINE INDUCES ANAUTONOMOUS PATTERN OF PROLIFERATION THAT CORRELATES WITH A LOSS OF BASAL AND STIMULATED PHOSPHOTYROSINE PHOSPHATASE-ACTIVITY

      Endocrinology
    81. VONESSEN R; OSTERMAIER R; GRUBE E; MAURER W; TEBBE U; ERBEL R; ROTH M; OEL W; BROM J; WEIDINGER G
      EFFECTS OF OCTREOTIDE TREATMENT ON RESTENOSIS AFTER CORONARY ANGIOPLASTY - RESULTS OF THE VERAS STUDY

      Circulation
    82. LIANG CP; PEYMAN GA; CONWAY MD; WOLTERING EA
      RETINAL TOXICITY OF INTRAVITREOUS OCTREOTIDE IN THE RABBIT

      Canadian journal of ophthalmology
    83. HRUBY VJ; LI GG; HASKELLLUEVANO C; SHENDEROVICH M
      DESIGN OF PEPTIDES, PROTEINS, AND PEPTIDOMIMETICS IN CHI-SPACE

      Biopolymers
    84. GUNAL AI; ISIK A; CELIKER H; EREN O; CELEBI H; GUNAL SY; LULECI C
      SHORT-TERM REDUCTION OF LEFT-VENTRICULAR MASS IN PRIMARY HYPERTROPHICCARDIOMYOPATHY BY OCTREOTIDE INJECTIONS

      HEART
    85. MAUREA S; LASTORIA S; CARACO C; KLAIN M; VARRELLA P; ACAMPA W; MUTO P; SALVATORE M
      THE ROLE OF RADIOLABELED SOMATOSTATIN ANALOGS IN ADRENAL IMAGING

      Nuclear medicine and biology
    86. DAMOUR D; BARREAU M; BLANCHARD JC; BURGEVIN MC; DOBLE A; HERMAN F; PANTEL G; JAMESSURCOUF E; VUILHORGNE M; MIGNANI S; POITOUT L; LEMERRER Y; DEPEZAY JC
      DESIGN, SYNTHESIS AND BINDING AFFINITIES OF NOVEL NONPEPTIDE MIMICS OF SOMATOSTATIN SANDOSTATIN(R)/

      Bioorganic & medicinal chemistry letters
    87. SKINAZI F; ZINS M; MENU Y; BERNADES P; RUSZNIEWSKI P
      LIVER METASTASES OF DIGESTIVE ENDOCRINE TUMORS - NATURAL-HISTORY AND RESPONSE TO MEDICAL-TREATMENT

      European journal of gastroenterology & hepatology
    88. YAM D; FINK A; MASHIAH A; BENHUR E
      HYPERINSULINEMIA IN COLON, STOMACH AND BREAST-CANCER PATIENTS

      Cancer letters
    89. KLIJN JGM; SETYONOHAN B; BONTENBAL M; SEYNAEVE C; FOEKENS J
      NOVEL ENDOCRINE THERAPIES IN BREAST-CANCER

      Acta oncologica
    90. SGAMBATI SA; ZARIF A; BASSON MD
      OCTREOTIDE DIFFERENTIALLY MODULATES HUMAN CACO-2 INTESTINAL EPITHELIAL-CELL PROLIFERATION AND DIFFERENTIATION BY DECREASING INTRACELLULAR CAMP

      Regulatory peptides
    91. BERGSTROM M; ERIKSSON B; OBERG K; SUNDIN A; AHLSTROM H; LINDNER KJ; BJURLING P; LANGSTROM B
      IN-VIVO DEMONSTRATION OF ENZYME-ACTIVITY IN ENDOCRINE PANCREATIC TUMORS - DECARBOXYLATION OF CARBON-11-DOPA TO CARBON-11-DOPAMINE

      The Journal of nuclear medicine
    92. DEHERDER WW; VANDERLELY AJ; LAMBERTS SWJ
      SOMATOSTATIN ANALOG TREATMENT OF NEUROENDOCRINE TUMORS

      Postgraduate medical journal
    93. VARNUM JM; THAKUR M; MAYO KH; JANSEN SA
      STABILITY AND CONFORMATIONAL-ANALYSIS OF TC-RC160 AND RE-RC160 - EXPERIMENTAL AND THEORETICAL-ANALYSIS OF THE INFLUENCE OF METAL COMPLEXATION ON THE STRUCTURAL REQUISITES FOR ACTIVITY

      Journal of physical chemistry
    94. TRAINA G; CANNISTRARO S; BAGNOLI P
      EFFECTS OF SOMATOSTATIN ON INTRACELLULAR CALCIUM-CONCENTRATION IN PC12 CELLS

      Journal of neurochemistry
    95. RUSZNIEWSKI P; DUCREUX M; CHAYVIALLE JA; BLUMBERG J; CLOAREC D; MICHEL H; RAYMOND JM; DUPAS JL; GOUEROU H; JIAN R; GENESTIN E; BERNADES P; ROUGIER P
      TREATMENT OF THE CARCINOID-SYNDROME WITH THE LONGACTING SOMATOSTATIN ANALOG LANREOTIDE - A PROSPECTIVE-STUDY IN 39 PATIENTS

      Gut
    96. POLLAK M
      ENHANCEMENT OF THE ANTINEOPLASTIC EFFECTS OF TAMOXIFEN BY SOMATOSTATIN ANALOGS

      Digestion
    97. DILEO A; BAJETTA E; FERRARI L; BIGANZOLI L; MARIANI L; CARNAGHI C; CAMERINI E; BUZZONI R; RUIZ JM
      A DOSE-FINDING STUDY OF LANREOTIDE (A SOMATOSTATIN ANALOG) IN PATIENTS WITH COLORECTAL-CARCINOMA

      Cancer
    98. TSUZUKI S; EGUCHI S; INAGAMI T
      INHIBITION OF CELL-PROLIFERATION AND ACTIVATION OF PROTEIN-TYROSINE-PHOSPHATASE MEDIATED BY ANGIOTENSIN-II TYPE-2 (AT(2)) RECEPTOR IN R3T3 CELLS

      Biochemical and biophysical research communications
    99. BOMBARDIERI E; CRIPPA F; CATALDO I; CHITI A; SEREGNI E; SORESI E; BOFFI R; INVERNIZZI G; BURAGGI GL
      SOMATOSTATIN RECEPTOR IMAGING OF SMALL-CELL LUNG-CANCER (SCLC) BY MEANS OF IN-111-DTPA OCTREOTIDE SCINTIGRAPHY

      European journal of cancer
    100. MARTINEZ V; COY DH; TACHE Y
      INFLUENCE OF INTRACISTERNAL INJECTION OF SOMATOSTATIN ANALOG RECEPTORSUBTYPE-2, SUBTYPE-3 AND SUBTYPE-5 ON GASTRIC-ACID SECRETION IN CONSCIOUS RATS

      Neuroscience letters


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/08/20 alle ore 23:57:10